Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Aug;63(8):3037–3041. doi: 10.1128/iai.63.8.3037-3041.1995

Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia.

S T Kanaly 1, S A Hines 1, G H Palmer 1
PMCID: PMC173413  PMID: 7622227

Abstract

Rhodococcus equi, a facultative intracellular bacterium, causes chronic, often fatal granulomatous pneumonia in young horses and in humans with AIDS. The inability of host alveolar macrophages to kill intracellular R. equi results in the development of granulomas and progressive loss of pulmonary parenchyma. Clearance of the organism from the lung requires functional CD4+ T cells. The purpose of this study was to identify the cytokine effector mechanisms that mediate clearance of R. equi from the lung. Mice were treated with monoclonal antibodies (MAbs) to either gamma interferon (IFN-gamma) or interleukin-4 (IL-4) to determine the role of endogenous production of these cytokines in pulmonary clearance of R. equi. Mice treated with an anti-IL-4 or isotype control MAb cleared R. equi by 21 days postinfection and expressed increased levels of IFN-gamma mRNA, as detected by transcriptional analysis of bronchial lymph node CD4+ T cells. In contrast, mice treated with the anti-IFN-gamma MAb failed to express detectable IFN-gamma mRNA, expressed increased levels of IL-4 mRNA, failed to clear pulmonary infection, and developed pulmonary granulomas with large numbers of eosinophils. The enhancement of IL-4 mRNA expression and a predominance of eosinophils in pulmonary lesions of anti-IFN-gamma-treated mice suggest that a nonprotective Th2 response in involved in disease pathogenesis. The association of increased bronchial lymph node CD4+ T-cell IFN-gamma mRNA expression with pulmonary clearance of R. equi suggests that a Th1 response is protective.

Full Text

The Full Text of this article is available as a PDF (801.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antinori S., Esposito R., Cernuschi M., Galli M., Galimberti L., Tocalli L., Moroni M. Disseminated Rhodococcus equi infection initially presenting as foot mycetoma in an HIV-positive patient. AIDS. 1992 Jul;6(7):740–742. doi: 10.1097/00002030-199207000-00022. [DOI] [PubMed] [Google Scholar]
  2. Belosevic M., Finbloom D. S., Van Der Meide P. H., Slayter M. V., Nacy C. A. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J Immunol. 1989 Jul 1;143(1):266–274. [PubMed] [Google Scholar]
  3. Bowles P. M., Woolcock J. B., Mutimer M. D. Experimental infection of mice with Rhodococcus equi: differences in virulence between strains. Vet Microbiol. 1987 Aug;14(3):259–268. doi: 10.1016/0378-1135(87)90113-1. [DOI] [PubMed] [Google Scholar]
  4. Cherwinski H. M., Schumacher J. H., Brown K. D., Mosmann T. R. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med. 1987 Nov 1;166(5):1229–1244. doi: 10.1084/jem.166.5.1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Daley C. L. Bacterial pneumonia in HIV-infected patients. Semin Respir Infect. 1993 Jun;8(2):104–115. [PubMed] [Google Scholar]
  6. Doig C., Gill M. J., Church D. L. Rhodococcus equi--an easily missed opportunistic pathogen. Scand J Infect Dis. 1991;23(1):1–6. doi: 10.3109/00365549109023367. [DOI] [PubMed] [Google Scholar]
  7. Gazzinelli R. T., Hakim F. T., Hieny S., Shearer G. M., Sher A. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol. 1991 Jan 1;146(1):286–292. [PubMed] [Google Scholar]
  8. Gazzinelli R. T., Hieny S., Wynn T. A., Wolf S., Sher A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6115–6119. doi: 10.1073/pnas.90.13.6115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Glaser C. A., Angulo F. J., Rooney J. A. Animal-associated opportunistic infections among persons infected with the human immunodeficiency virus. Clin Infect Dis. 1994 Jan;18(1):14–24. doi: 10.1093/clinids/18.1.14. [DOI] [PubMed] [Google Scholar]
  10. Gray B. M. Case report: Rhodococcus equi pneumonia in a patient infected by the human immunodeficiency virus. Am J Med Sci. 1992 Mar;303(3):180–183. doi: 10.1097/00000441-199203000-00010. [DOI] [PubMed] [Google Scholar]
  11. Harvey R. L., Sunstrum J. C. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis. 1991 Jan-Feb;13(1):139–145. doi: 10.1093/clinids/13.1.139. [DOI] [PubMed] [Google Scholar]
  12. Kanaly S. T., Hines S. A., Palmer G. H. Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice. Infect Immun. 1993 Nov;61(11):4929–4932. doi: 10.1128/iai.61.11.4929-4932.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kopf M., Le Gros G., Bachmann M., Lamers M. C., Bluethmann H., Köhler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 1993 Mar 18;362(6417):245–248. doi: 10.1038/362245a0. [DOI] [PubMed] [Google Scholar]
  14. Libanore M., Rossi M. R., Bicocchi R., Ghinelli F. Rhodococcus equi pneumonia and occult HIV infection. Lancet. 1993 Aug 21;342(8869):496–497. doi: 10.1016/0140-6736(93)91623-t. [DOI] [PubMed] [Google Scholar]
  15. McGowan K. L., Mangano M. F. Infections with Rhodococcus equi in children. Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):347–352. doi: 10.1016/0732-8893(91)90026-c. [DOI] [PubMed] [Google Scholar]
  16. Mills K. H., Barnard A., Watkins J., Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun. 1993 Feb;61(2):399–410. doi: 10.1128/iai.61.2.399-410.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi: 10.1146/annurev.iy.07.040189.001045. [DOI] [PubMed] [Google Scholar]
  18. Murray H. W., Hariprashad J. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J Exp Med. 1995 Jan 1;181(1):387–391. doi: 10.1084/jem.181.1.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nakazawa M., Haritani M., Sugimoto C., Isayama Y. Virulence of Rhodococcus equi for mice. Nihon Juigaku Zasshi. 1983 Oct;45(5):679–682. doi: 10.1292/jvms1939.45.679. [DOI] [PubMed] [Google Scholar]
  20. Nordmann P., Kerestedjian J. J., Ronco E. Therapy of Rhodococcus equi disseminated infections in nude mice. Antimicrob Agents Chemother. 1992 Jun;36(6):1244–1248. doi: 10.1128/aac.36.6.1244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nordmann P., Ronco E., Guenounou M. Involvement of interferon-gamma and tumor necrosis factor-alpha in host defense against Rhodococcus equi. J Infect Dis. 1993 Jun;167(6):1456–1459. doi: 10.1093/infdis/167.6.1456. [DOI] [PubMed] [Google Scholar]
  22. Nordmann P., Ronco E., Nauciel C. Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect Immun. 1992 Jul;60(7):2748–2752. doi: 10.1128/iai.60.7.2748-2752.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ohara J., Paul W. E. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature. 1985 May 23;315(6017):333–336. doi: 10.1038/315333a0. [DOI] [PubMed] [Google Scholar]
  24. Prescott J. F. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev. 1991 Jan;4(1):20–34. doi: 10.1128/cmr.4.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Scannell K. A., Portoni E. J., Finkle H. I., Rice M. Pulmonary malacoplakia and Rhodococcus equi infection in a patient with AIDS. Chest. 1990 Apr;97(4):1000–1001. doi: 10.1378/chest.97.4.1000. [DOI] [PubMed] [Google Scholar]
  26. Scott P. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol. 1991 Nov 1;147(9):3149–3155. [PubMed] [Google Scholar]
  27. Siebert P. D., Larrick J. W. PCR MIMICS: competitive DNA fragments for use as internal standards in quantitative PCR. Biotechniques. 1993 Feb;14(2):244–249. [PubMed] [Google Scholar]
  28. Takai S., Koike K., Ohbushi S., Izumi C., Tsubaki S. Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi. J Clin Microbiol. 1991 Mar;29(3):439–443. doi: 10.1128/jcm.29.3.439-443.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Takai S., Michizoe T., Matsumura K., Nagai M., Sato H., Tsubaki S. Correlation of in vitro properties of Rhodococcus (Corynebacterium) equi with virulence for mice. Microbiol Immunol. 1985;29(12):1175–1184. doi: 10.1111/j.1348-0421.1985.tb00907.x. [DOI] [PubMed] [Google Scholar]
  30. Takai S., Sekizaki T., Ozawa T., Sugawara T., Watanabe Y., Tsubaki S. Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi. Infect Immun. 1991 Nov;59(11):4056–4060. doi: 10.1128/iai.59.11.4056-4060.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Takasugi J. E., Godwin J. D. Lung abscess caused by Rhodococcus equi. J Thorac Imaging. 1991 Apr;6(2):72–74. doi: 10.1097/00005382-199104000-00016. [DOI] [PubMed] [Google Scholar]
  32. Tkachuk-Saad O., Prescott J. Rhodococcus equi plasmids: isolation and partial characterization. J Clin Microbiol. 1991 Dec;29(12):2696–2700. doi: 10.1128/jcm.29.12.2696-2700.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Verville T. D., Huycke M. M., Greenfield R. A., Fine D. P., Kuhls T. L., Slater L. N. Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine (Baltimore) 1994 May;73(3):119–132. doi: 10.1097/00005792-199405000-00001. [DOI] [PubMed] [Google Scholar]
  34. Vestbo J., Lundgren J. D., Gaub J., Røder B., Gutschik E. Severe Rhodococcus equi pneumonia: case report and literature review. Eur J Clin Microbiol Infect Dis. 1991 Sep;10(9):762–768. doi: 10.1007/BF01972506. [DOI] [PubMed] [Google Scholar]
  35. Wang A. M., Doyle M. V., Mark D. F. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9717–9721. doi: 10.1073/pnas.86.24.9717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Weingarten J. S., Huang D. Y., Jackman J. D., Jr Rhodococcus equi pneumonia. An unusual early manifestation of the acquired immunodeficiency syndrome (AIDS). Chest. 1988 Jul;94(1):195–196. doi: 10.1378/chest.94.1.195. [DOI] [PubMed] [Google Scholar]
  37. Woolcock J. B., Farmer A. M., Mutimer M. D. Selective medium for Corynebacterium equi isolation. J Clin Microbiol. 1979 May;9(5):640–642. doi: 10.1128/jcm.9.5.640-642.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Yager J. A., Prescott C. A., Kramar D. P., Hannah H., Balson G. A., Croy B. A. The effect of experimental infection with Rhodococcus equi on immunodeficient mice. Vet Microbiol. 1991 Aug 30;28(4):363–376. doi: 10.1016/0378-1135(91)90071-m. [DOI] [PubMed] [Google Scholar]
  39. Yager J. A. The pathogenesis of Rhodococcus equi pneumonia in foals. Vet Microbiol. 1987 Aug;14(3):225–232. doi: 10.1016/0378-1135(87)90109-x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES